(2R,5S)-rel-Diethyl 2,5-dibromohexanedioate

Catalog No. :
ACPJMK672
CAS No. :
54221-37-3
Molecular Formula :
C10H16Br2O4
Molecular Weight :
360.04

IUPAC Name:diethyl (2R,5S)-2,5-dibromohexanedioate

(2R,5S)-rel-Diethyl 2,5-dibromohexanedioate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$72.00Login to see priceIn stockInquiry
500g98%$292.00Login to see priceIn stockInquiry
1000g98%$497.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,5S)-rel-Diethyl 2,5-dibromohexanedioate
IUPAC Namediethyl (2R,5S)-2,5-dibromohexanedioate
MDL No.MFCD00075379
Molecular FormulaC10H16Br2O4
Molecular Weight360.04
SMILESO=C(OCC)[C@H](Br)CC[C@H](Br)C(OCC)=O
InChI KeyUBCNJHBDCUBIPB-OCAPTIKFSA-N
SynonymFS-3941 | diethyl (2S,5R)-2,5-dibromohexanedioate | AKOS005255265 | Diethyl meso-2,5-dibromoadipate | CS-0197717 | GEO-01041 | (2R,5S)-rel-Diethyl2,5-dibromohexanedioate | (2S,5R)-Dibromo-hexanedioic acid diethyl ester | A870523 | SCHEMBL240521 | Diethyl
CAS No.54221-37-3
PubChem CID6994100

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P233-P260-P261-P264-P271-P280-P302+P352-P304-P304+P340-P305+P351+P338-P312-P321-P332+P313-P337+P313-P340-P362-P403-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACPJMK672 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPJMK672 route product structure diagram
    ACPJMK67254221-37-3 In Stock
Inquiry

2. ACPJMK672 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPJMK672 route product structure diagram
    ACPJMK67254221-37-3 In Stock
Inquiry

Comments (0)